Inventor · disambiguated record
Patrick Holder
Also filed as: HOLDER PATRICK G · HOLDER PATRICK GWYNN · Holder Patrick
8 granted patents·5 pending applications·3 citations·filing 2007–2025
79Inventor score
Top patents by PatentIndex Score
13 records- 0191US11932675B2PD-1 targeted IL-15/IL-15Rα Fc fusion proteins with improved propertiesGENENTECH INC·Filed 2020·Granted Mar 19, 2024·2 cites·15 claims
- 0284US12018308B2Activated formylglycine-generating enzymes and methods of producing and using the sameSCHERER TECHNOLOGIES LLC R P·Filed 2023·Granted Jun 25, 2024·0 cites·20 claims
- 0377US11655492B2Activated formylglycine-generating enzymes and methods of producing and using the sameSCHERER TECHNOLOGIES LLC R P·Filed 2021·Granted May 23, 2023·0 cites·10 claims
- 0474US9951367B2Activated formylglycine-generating enzymes and methods of producing and using the sameSCHERER TECHNOLOGIES LLC R P·Filed 2015·Granted Apr 24, 2018·1 cites·16 claims
- 0573US11053529B2Activated formylglycine-generating enzymes and methods of producing and using the sameSCHERER TECHNOLOGIES LLC R P·Filed 2020·Granted Jul 6, 2021·0 cites·25 claims
- 0673US2024294593A1Pd-1 targeted il-15/il-15ralpha fc fusion proteins with improved propertiesGENENTECH INC·Filed 2024·Application pending·0 cites
- 0772US10683527B2Activated formylglycine-generating enzymes and methods of producing and using the sameSCHERER TECHNOLOGIES LLC R P·Filed 2019·Granted Jun 16, 2020·0 cites·37 claims
- 0865US10344311B2Activated formylglycine-generating enzymes and methods of producing and using the sameSCHERER TECHNOLOGIES LLC R P·Filed 2018·Granted Jul 9, 2019·0 cites·24 claims
- 0960US2023192760A1Systems and methods for tyrosinase-mediated site-specific protein conjugationGENENTECH INC·Filed 2022·Application pending·0 cites
- 1058US2024376509A1Methods of Controlling Cleavage of Formylglycine-Containing PolypeptidesSCHERER TECHNOLOGIES LLC R P·Filed 2022·Application pending·0 cites
- 1154US2011104051A1Chemically Modified Viral Capsids as Targeted Delivery Vectors for Diagnostic and Therapeutic AgentsUNIV CALIFORNIA·Filed 2007·Application pending·0 cites
- 1253US12290570B2Antibody comprising a glutamine-containing light chain C-terminal extension, conjugates thereof, and methods and usesBRISTOL MYERS SQUIBB CO·Filed 2019·Granted May 6, 2025·0 cites·23 claims
- 1345US2025205309A1Combinations of il15/il15r alpha heterodimeric fc-fusion proteins and fcrh5xcd3 bispecific antibodies for the treatment of blood cancersGENENTECH INC·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Patrick Holder files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →